HCA(US:HCA) Financial Modeling Prep·2026-01-26 14:00Core Viewpoint - HCA Healthcare is expected to report significant growth in its quarterly earnings, with an anticipated EPS of $7.36 and revenue of approximately $19.67 billion, driven by higher admissions and occupancy rates [2][6]. Financial Performance - The upcoming earnings report for the quarter ended December 2025 is projected to show an EPS of $7.36, representing an 18.3% increase year-over-year [2]. - Revenue is expected to reach $19.67 billion, indicating a 7.4% year-over-year increase, attributed to higher admissions, increased occupancy, and rising revenue per admission [2][6]. Challenges - Despite the positive growth outlook, HCA faces challenges such as higher operating expenses and supply-cost inflation, along with a potential decrease in outpatient surgeries that could impact overall results [3][6]. Market Valuation - HCA's market valuation is reflected in its P/E ratio of approximately 17.91, a price-to-sales ratio of about 1.44, and an enterprise value to sales ratio of around 2.05 [4][6]. Financial Health - The company's earnings yield is about 5.58%, and it has a negative debt-to-equity ratio of -8.69, indicating a higher level of debt compared to its equity [5]. - HCA's current ratio is approximately 0.85, suggesting its ability to cover short-term liabilities with short-term assets, which is crucial for assessing liquidity [5].